采用标准化 12 色流式细胞术评估 B 细胞前体急性淋巴细胞白血病 CD19 靶向治疗后的微小残留病：一项 EuroFlow 研究
Minimal residual disease assessment following CD19-targeted therapy in B-cell precursor acute lymphoblastic leukemia using standardized 12-color flow
67.4分
★★★☆☆
站内排序·非疗效